Official registry condition

Coronary Disease peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Coronary Disease. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

2 profiles.

Registry update years

2010–2014 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles2

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases2

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 60 selected PubMed records and 29 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Coronary Disease unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00262054

PeptideScanner retained ClinicalTrials.gov record NCT00262054 at 2026-11-15T21:58:19.888Z. Its registry update date was 2010-03-15, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
March 15, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00317395

PeptideScanner retained ClinicalTrials.gov record NCT00317395 at 2026-11-15T21:59:29.646Z. Its registry update date was 2014-12-03, and PeptideScanner's reviewed identity mapping was eptifibatide.

PeptideScanner change date
November 15, 2026
Cited source date
December 3, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00373451

PeptideScanner retained ClinicalTrials.gov record NCT00373451 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.

PeptideScanner change date
November 15, 2026
Cited source date
May 8, 2012
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →